Molybdenum cofactor deficiency, type a Clinical Trials
Conditions / Molybdenum cofactor deficiency, type a
Delta Trials indexes 3 clinical trials for Molybdenum cofactor deficiency, type a in its publicly accessible dataset. Of these, 0 enrolling participants at this time and 2 trials have reached completion. This research takes place spanning 15 research sites around the world. An additional 1 trial are in preparatory or other active non-recruiting stages. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
3
Total Trials
0
Recruiting
2
Completed
1
Other Active
0
Terminated since 2020
15
Study Locations
Browse by location (15 total)
- Manchester, United Kingdom 2 trialsAll trials in Manchester, United Kingdom
- Milwaukee, United States 2 trialsAll trials in Milwaukee, United States
- All trials in Research Triangle Park, United States
- Glasgow, United Kingdom 1 trialAll trials in Glasgow, United Kingdom
- Cincinnati, United States 1 trialAll trials in Cincinnati, United States
- Afula, Israel 1 trialAll trials in Afula, Israel
- Detroit, United States 1 trialAll trials in Detroit, United States
- Esplugues de Llobregat, Spain 1 trialAll trials in Esplugues de Llobregat, Spain
- London, United Kingdom 1 trialAll trials in London, United Kingdom
- Antalya, Turkey (türkiye) 1 trialAll trials in Antalya, Turkey (türkiye)
- Ankara, Turkey (türkiye) 1 trialAll trials in Ankara, Turkey (türkiye)
- Melbourne, Australia 1 trialAll trials in Melbourne, Australia
- Groningen, Netherlands 1 trialAll trials in Groningen, Netherlands
- Stavanger, Norway 1 trialAll trials in Stavanger, Norway
- Tunis, Tunisia 1 trialAll trials in Tunis, Tunisia